(1) Background: In many infections, antibodies play a crucial role in controlling infection. In COVID-19, the dynamics of the immune system response to SARS-CoV-2 is not fully understood. (2) Methods: The study was conducted on 120 healthcare workers from Dr. Antoni Jurasz University Hospital No. 1 in Bydgoszcz, between June and December 2020. In all participants, IgA and IgG antibody serum concentrations were measured using the semi-quantitative Anti-SARS-CoV-2 ELISA test (Euroimmun). After vaccination, in January and February 2021, antibody levels were examined using the quantitative IgG Anti-SARS-CoV-2 Quantivac ELISA test (Euroimmun). (3) Results: During the whole study period, the SARS-CoV-2 infection was confirmed in 29 (24.2%) participants. In all infected participants, IgA and IgG antibodies were detectable after infection by semi-quantitative serological tests. Levels of antibodies were higher one month after the first dose in the convalescents than in the non-previously infected participants. In this second group, the level of antibodies increased significantly after the second dose of vaccines compared to the first dose. (4) Conclusions: The level of antibodies after the first dose of vaccine in the convalescents’ group is higher than in the SARS-CoV-2 non-infected group, but the differences disappear after the second vaccination.
【저자키워드】 antibodies, SARS-CoV-2, vaccination, Immunological response, 【초록키워드】 COVID-19, IgG, Vaccine, antibody, Infection, immune system, healthcare worker, serum, infections, IgG antibody, IgA, convalescent, university, serological, Quantitative, Concentration, Participants, second vaccination, second dose, first dose, study period, ELISA test, non-infected, examined, significantly, detectable, conducted, Level, semi-quantitative, were measured, the SARS-CoV-2, 【제목키워드】 Poland, mRNA, group, worker, second, difference, Level,